Simpson Adam K. 4
4 · Icosavax, Inc. · Filed Jan 23, 2024
Insider Transaction Report
Form 4
Icosavax, Inc.ICVX
Simpson Adam K.
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-01-22−93,227→ 206,449 totalExercise: $1.04Exp: 2031-01-28→ Common Stock (93,227 underlying) - Exercise/Conversion
Common Stock
2024-01-22$1.04/sh+93,227$96,956→ 358,657 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-01-22−4,789→ 0 totalExercise: $0.84Exp: 2030-05-10→ Common Stock (4,789 underlying) - Exercise/Conversion
Common Stock
2024-01-22$0.84/sh+4,789$4,023→ 265,430 total
Holdings
- 129,032(indirect: By Trust)
Common Stock
- 531,576(indirect: By Trust)
Common Stock
- 129,032(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]25% of the shares subject to the option vested on February 21, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.
- [F2]25% of the shares subject to the option vested on January 14, 2022, and 1/48th of the shares subject to the option vest monthly thereafter.